Ads
related to: revlimid- Treatment Option
Find Out More Info About Jaypirca.
Learn About a Treatment Option.
- Learn About Jaypirca
Find Out About Jaypirca.
Read More on the Official Site.
- Taking Jaypirca
Dosing Information.
Side Effects and Safety.
- Support and Resources
Find Out If You Qualify For
Financial Assistance.
- Treatment Option
Search results
Bristol Myers' profit beats on better-than-feared Revlimid sales
Reuters via Yahoo Finance· 1 year ago(Reuters) -Bristol Myers Squibb Co on Thursday reported quarterly earnings that beat analysts'...
Bristol Myers sales fall, cuts 2023 forecast as drugs face competition
Reuters via Yahoo News· 10 months ago(Reuters) -Bristol Myers Squibb on Thursday said its second-quarter sales fell more than expected...
Bristol Myers profit beats estimates on resilient Revlimid sales
Reuters via Yahoo Finance· 2 years ago(Reuters) -Bristol Myers Squibb Co on Wednesday reported bigger second-quarter profit than expected...
Bristol Myers Squibb Proved in Q3 Why Its Diverse Portfolio Makes It a Solid Investment
Motley Fool· 7 months agoBristol Myers Squibb (NYSE: BMY) is one of the largest healthcare companies in the world. The...
Bristol Myers Q3 sales fall on Revlimid, forex pressure
Reuters via Yahoo Finance· 2 years agoSales and earnings in the quarter were still better than expected as sales of Revlimid did not drop...
Bristol-Myers (BMY) Q3 Earnings Beat, Sales Decline Y/Y
Zacks via Yahoo Finance· 2 years agoBristol-Myers Squibb Company BMY reported decent results for the third quarter of 2022. The company...
Bristol-Myers (BMY) Q2 Earnings, Sales Beat on Eliquis, Opdivo
Zacks via Yahoo Finance· 2 years agoBristol-Myers (BMY) earnings and sales beat estimates in the second quarter of 2022 on the back of...
A Patent Cliff Is Coming For Bristol Myers — Can Billions In New Products Fill The Gap?
Investor's Business Daily· 1 year agoIt's a new day at Bristol Myers Squibb, according to a company executive. But BMY stock remains...
Is Bristol Myers Squibb Stock a Buy Now?
Motley Fool via Yahoo Finance· 4 months agoIt's not exactly fun to be one of Bristol Myers Squibb's (NYSE: BMY) shareholders right now. The company's stock dropped by 31% in the past year, some of...
Bristol Myers Squibb Posts Lower Q1 Sales As Revlimid Generic Erosion Bites, Chairman & CEO Giovanni...
Benzinga via Yahoo Finance· 1 year agoView more earnings on BMYDon't miss real-time alerts on your stocks - join Benzinga Pro for free!...
Ad
related to: revlimid